TBG Terrabiogen Technologies

NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TerraBioGen Technologies Inc. (TSX VENTURE:TBG), a developer and marketer of
proprietary technologies for the production of organic-based, high-value
agricultural products from organic wastes, announces the results of crop trials
during the 2011 growing season.


The Company conducted growing trials through the summer of 2011 in Ontario on
field tomatoes and potatoes. The tomato trials, which were carried out in a
grower's field in collaboration with the Ridgetown Campus of the University of
Guelph under the management of A&L Biologicals of London, Ontario, consisted of
at least four replications comparing TerraBioGen product against the grower's
standard treatment and several competitive products. In trials with both
potatoes and tomatoes the TerraBioGen products outperformed the controls and
competitive products and showed up to 35% yield increase in tomatoes and a 29%
yield increase in potatoes over the grower's standard. The use of the
TerraBioGen product showed evidence of reduced levels of some pathogens known to
cause root lesions associated with tomato vine decline. Increased growth
responses and healthier plants were clearly demonstrated in growth room studies
carried out with wheat, cucumber and radishes.


Blair Heffelfinger, President and CEO of TerraBioGen, said: "It is a pleasure to
work with two of Canada's leading agricultural research organizations - the
University of Guelph and A&L Biologicals. These results confirm what we have
seen in the past with our products. This is the first phase of a two year
project and we anticipate further advances in performance as we continue to
improve our products."


Dr. George Lazarovits, the Chief Technical Officer of A&L Biologicals, said: "We
are pleased with the on-going collaboration with TerraBioGen and have seen a
general increase in crop health and yields, and reduced disease incidence with
the use of their product. We look forward to continue working with TerraBioGen
to further understand and improve the performance of their products to the
benefit of the agricultural community."


About TerraBioGen Technologies

Located in North Vancouver, BC, TerraBioGen Technologies Inc. is committed to
research and development to continue to improve the efficiency of its technology
and the quality of its agricultural products. It is further committed to
developing a world-wide marketing capability to ensure market acceptance of its
products.


About A&L Biologicals

A&L Biologicals is located in London Ontario in a state-of-the-art laboratory
focused on technologies that are based on ecological principles to help growers
increase crop yields, reduce fertilizer costs, increase plant growth and
nutrient uptake, control soilborne pests and disease, and promote practices that
benefit the environment.


This news release contains certain statements that may be deemed
"forward-looking" statements. Forward looking statements are statements that are
not historical facts and are generally, but not always, identified by the words
"expects", "plans", "anticipates", "believes", "intends", "estimates",
"projects", "potential" and similar expressions, or that events or conditions
"will", "would", "may", "could" or "should" occur. Although TerraBioGen believes
the expectations expressed in such forward-looking statements are based on
reasonable assumptions, such statements are not guarantees of future performance
and actual results may differ materially from those in forward looking
statements. Forward looking statements are based on the beliefs, estimates and
opinions of TerraBioGen's management on the date the statements are made. Except
as required by law, TerraBioGen undertakes no obligation to update these
forward-looking statements in the event that management's beliefs, estimates or
opinions, or other factors, should change.


THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR
DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES,
AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD
IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Terrabiogen Technologies (TSXV:TBG)
Historical Stock Chart
From May 2024 to Jun 2024

Terrabiogen Technologies (TSXV:TBG)
Historical Stock Chart
From Jun 2023 to Jun 2024